Biography
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
UCSF | Transplant Hepatology Fellowship | 2013 | |
UCSF | Gastroenterology Fellowship | 2012 | |
UCSF | M.A.S. in Clinical Research | Graduate Division (Advance Training in Clinical Research) | 2012 |
University of Pennsylvania | Internal Medicine Residency | 2009 | |
UCSF | M.D. | School of Medicine | 2006 |
Vassar College | BA | 2002 |
Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine - Gastroenterology
American Board of Internal Medicine - Transplant Hepatology
Awards & Honors
Award | Conferred By | Date |
---|---|---|
R03 | NIDDK | 2022/2024 |
K23 | NIDDK | 2017/2023 |
K Scholars Team Science Award | UCSF | 2017/2018 |
UCSF Hellman Research Award | UCSF | 2016/2018 |
RAP Pilot Award for Junior Investigators | UCSF | 2016/2017 |
Liver Center Flex Funds | UCSF | 2015/2016 |
Liver Center Pilot/Feasibility Research Award | UCSF Liver Center | 2014/2015 |
Sheila Sherlock Career Development Research Award | AASLD | 2013/2015 |
Advanced Hepatology Fellowship Award | AASLD | 2012/2013 |
Clinical Expertise
Alcoholic Liver Disease
Autoimmune Hepatitis
Cirrhosis
Drug-Induced Hepatitis
Fulminant Hepatic Failure
Hemochromatosis
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Liver Transplantation
Living Donor Liver Transplantation
Nonalcoholic Fatty Liver Disease
Polycystic Liver Disease
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis
Clinical Trials
- Bicalutamide Therapy in Young Women With NAFLD and PCOS (NCT05979389)Related Conditions: Nonalcoholic Fatty Liver Disease, Polycystic Ovary Syndrome, Liver Disease| Start Date: | End Date:
- Spironolactone Therapy In Young Women With NASH (NCT03576755)Related Conditions: Nonalcoholic Steatohepatitis, Steatohepatitis, Liver Disease, Nonalcoholic Fatty Liver Disease| Start Date: | End Date:
Program Affiliations
UCSF Liver Center
Grants and Funding
- Influence of Androgens on Tissue-Specific Lipid Metabolites and Liver Injury in Young Women with NAFLD | NIDDK | 2022-03-15 - 2024-03-15 | Role: Principle Investigator
- Androgens and Nonalcoholic Steatohepatitis: The Role of Male Sex Hormones in Women with NASH | NIH | 2017-07-10 - 2023-06-30 | Role: Principal Investigator
Research Narrative
My research program is focused on the role of sex hormones on liver injury in women, including the effects of reproductive aging, pregnancy, and androgens. I have a specific interest in young women with the hyperandrogenic condition known as Polycystic Ovarian Syndrome as these women are at high risk for developing Non Alcoholic Fatty Liver Disease and early onset liver scarring. Within the transplant setting I also study sex differences in waitlist and post transplant outcomes.
Research Interests
Women with chronic liver disease
Non invasive measures of liver fibrosis
Gender differences in liver transplant outcomes
Publications
- 352 Sex Differences in Acetaminophen-Induced Acute Liver Injury and Acute Liver Failure.| | UCSF Research Profile
- Association between markers of non-alcoholic fatty liver disease and glucose tolerance in polycystic ovarian syndrome population.| | UCSF Research Profile
- Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.| | PubMed
- PS073 Light to Moderate Alcohol Use is not Associated with Long-Term Progression of Liver Fibrosis in Hiv Hcv Coinfected Women.| | UCSF Research Profile
- PS077 Sex Differences in Acetaminophen-Induced Acute Liver Injury and Acute Liver Failure.| | UCSF Research Profile
- Association of IFNL3 and IFNL4 polymorphisms with liver-related mortality in a multiracial cohort of HIV/HCV-coinfected women.| | PubMed
- Outcomes in liver transplantation: does sex matter?| | PubMed
- Ending vertical transmission of hepatitis B: the third trimester intervention.| | PubMed
- Characteristics and management of patients with chronic hepatitis B in an integrated care setting.| | PubMed
- Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.| | PubMed